Table 2. Average daily liquid intake per mouse and calculated IgA, IgG and LF intake.
| Treatment | Average liquid intake (mL/mouse/day) | Intake (μg/gram mouse/day) | ||
|---|---|---|---|---|
| SMP | IgA | IgG | Lf | |
| Water | 2.96 | 0 | 0 | 0 |
| SMP high* | 4.09 | 79 | 132 | 23 |
| SMP mid-high | 3.74 | 47 | 84 | 14 |
| SMP mid-low | 3.68 | 26 | 71 | 10 |
| SMP low | 3.71 | 14 | 57 | 6 |
| Colostrum commercial | 3.78 | 0 | 15 | 0 |
| SMP commercial | 3.50 | 0 | 0 | 0 |
| Water no infection | 2.85 | 0 | 0 | 0 |
| WPC | ||||
| Water | 3.18 | 0 | 0 | 0 |
| WPC high | 3.66 | 309 | 440 | 84 |
| WPC mid-high | 3.81 | 214 | 328 | 57 |
| WPC mid-low | 3.97 | 109 | 219 | 25 |
| WPC low | 4.26 | 48 | 163 | 4 |
| SMP high* | 4.01 | 65 | 107 | 18 |
| WPC commercial | 3.68 | 88 | 224 | 16 |
| Water no infection | 2.96 | 0 | 0 | 0 |
Notes:
SMP and WPC preparations were blended to produce treatments with a range of IgA, IgG and LF levels. Average amount per mouse was calculated from intake volume per cage.
SMP, skimmed milk powder; WPC, whey protein concentrate; Ig, immunoglobulin.
*
Indicates the same product used in both trials.